Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 269-279

  Bonde, Jesper ^a   Meyer, Karin ^a   Broe, Marianne Kjæervig ^b   Hokland, Marianne ^c   Turley, Helen ^d   Hokland, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AGILENT TECHNOLOGIES   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

CD13; CD14; CD66; Flow cytometry; Myelopoiesis; Triple marking

Indexed keywords

CD14 ANTIGEN; CD66 ANTIGENS; CELL ADHESION MOLECULE; DIAGNOSTIC AGENT; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; TUMOR MARKER;

ACUTE DISEASE; ARTICLE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; METHODOLOGY; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; BONE MARROW; HUMAN CELL; IMMUNOFLUORESCENCE; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION; CELL ADHESION MOLECULES; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; TUMOR MARKERS, BIOLOGICAL;

EID: 0029671305     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Adriaansen, H.J., te Boekhorst, P.A.W., Hagemeijer, A.M., van der Schoot, C.E., Deiwel, H.R. & van Dongen, J.J.M. (1993) Acute myeloid leukemia Mø with bone marrow eosinophilia and Inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood, 81, 3043-3051.
2. Bradstock, K., Kirk, J., Grimsley, P.G., Kabral, A. & Hughes, W.G. (1989) Unusual immunophenotypes in acute leukaemia: incidence and clinical correlations. British Journal of Haematology, 72, 512-518.
3. Bradstock, K., Matthews, J., Benson, E., Page, F. & Bishop, J. (1994) Prognostic value of immunophenotyping in acute myeloid leukemia. Blood, 84, 1220-1225.
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralrick, H.R. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. British Journal of Haematology, 33, 451-458.
5. Bordessoule, D., Jones, M., Gatter, K.C. & Mason, D.Y. (1993) Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. British Journal of Haematology, 83, 370-383.
6. Campana, D., Coustan-Smith, E. & Behm, F.G. (1991) The definition of remission in acute leukemia with immunologic techniques. Bone Marrow Transplantation, 8, 429-437.
7. Campana, D., Coustan-Smith, E. & Jannossy, G. (1990) The immunologic detection of minimal residual disease in acute leukemia. Blood, 76, 163-171.
8. Campana, D. & Pui, C.-H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 1416-1434.
9. Cassileth, P.A., Lynch, E., Hines, J.D., Oken, M.M., Mazza, J.J., Bennett, J.M., McGlave, P.B., Edelstein, M., Harrington, D.P. & O'Connell, M.J. (1992) Varying intensity of post-remission therapy in acute myeloid leukemia. Blood, 79, 1924.
10. Del Poeta, G., Stasi, R., Venditti, A., Suppo, G., Aronica, G., Bruno, A., Masi, M., Tabilio, A. & Papa, G. (1994), Prognostic value of cell marker analysis in de novo acute myeloid leukaemia. Leukemia, 8, 388-394.
11. Drexler, H.G., Thiel, E. & Ludwig, W.D. (1991) Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia, 5, 637-645.
12. Freeman, S.D., Kelm, S., Barber, E.K. & Crocker, P.R. (1995) Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction melecules. Blood, 85, 2005-2012.
13. Gilmore, M.J.M.L. & Prentice, H.G. (1986) Standardization of the processing of human bone marrow or allogenic transplantation. Vox Sanguinis, 51, 202-206.
14. Griffin, J.D., Linch, D., Sabbath, K., Larcom, P. & Schlossmann, S.F. (1984) A monoclonal antibody resctive with normal and leukemic human myeloid progenitor cells. Leukemia Research, 8, 521-534.
15. Griffin, J.D., Ritz, J., Nadler, L.M. & Schlossman, S.F. (1981) Expression of myeloid differentiation antigens on normal and malignant myeloid cells. Journal of Clinical Investigation, 68, 932-941.
16. Hokland, P., Kerndrup, G., Griffin, J.D. & Ellegaard, J. (1986) Analysis of leucocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood, 67, 898-902.
17. Kerndrup, G., Bendix-Hansen, K., Pedersen, B., Ellegaard, J. & Hokland, P. (1988) Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts: prognostic implications of sequential and follow-up data. European Journal of Haematology, 41, 368-374.
18. Kristensen, J.S. (1993) Immunophenotyping in acute leukemia, myelodysplastic syndromes and hairy cell leukemia: the use of monoclonal antibodies against myeloid differentiation antigens. Lægeforeningens Forlag, Copenhagen, Denmark.
19. Kristensen, J.S., Ellegaard, J., Hansen, K.B., Clausen, N. & Hokland, P. (1988) First-line diagnosis based on immunological phenotyping in suspected acute leukemia: a prospective study. Leukemia Research, 12, 773-782.
20. Kristensen, J.S. & Hokland, P. (1990) Monoclonal antibody ratios in malignant myeloid disease: prognostic use in myelodysplastic syndromes. British Journal of Haematology, 74, 270-276.
21. Kristensen, J.S. & Hokland, P. (1991) Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukemia. Leukemia Research, 15, 693-700.
22. Paietta, E., Andersen, J., Gallagher, R., Bennett, J., Yunis, J., Cassileth, P., Rowe, J. & Wiernik, P.H. (1994) The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia, 8, 1108-1112.
23. Reading, C.L., Estey, E.H., Huh, Y.O., Claxton, D.F., Sanchez, G., Terstappen, L.W.M.M., O'Brien, M.C., Baron, S. & Deisseroth, A.B. (1993) Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood, 81, 3083-3090.
24. San Miguel, J.F., Hernandéz, J.M., González-Sarmiento, R., González, M., Sánchez, I., Orfao, A., Cañizo, M.C. & López Borrasca, A. (1991) Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics. Blood, 78, 768-774.
25. + cells. Blood, 85, 194-202.
26. Second MIC Cooperative Study Group (1988) Morphologic, immunologic and cytogenetic (MIC) working classification of acute myeloid leukaemias. British Journal of Haematology, 68, 487-494.
27. Skov Madsen, P., Hokland, P., Clausen, N., Ellegaard, J. & Hokland, M. (1995) Differential expression levels of the heat shock protein 27 isoforms in pediatric normal, nonleukemic and common lymphoblastic leukemia B-cell precursors. Blood, 85, 510-521, 1995.
28. Skubitz, K.M., Micklem, K. & Van der Schoot, E. (1995) 5th International Workshop on Human Leucocyte Differentiation Antigens, pp. 889-921. Oxford University Press.
29. Stasi, R., Del Poeta, G., Venditti, A., Masi, M., Stipa, E., Dentamaro, T., Cox Cristina, Dallapiccola, B. & Papa, G. (1994) Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-MO). Blood, 83, 1619-1625.
30. Syrjälä, M., Anttila, V.J., Ruutu, T. & Jansson, S.E. (1994) Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens. Leukemia, 8, 1564-1570.
31. Terstappen, L.W.W.M., Könemann, S., Safford, M., Loken, M.R., Zurlutter, K., Büchner, Th., Hiddemann, W. & Wörmann, B. (1990a) Quantitative comparison of myeloid antigens on five lineages of mature myeloid peripheral blood cells. Journal of Leukocyte Biology, 48, 138-148.
32. Terstappen, L.W.W.M., Könemann, S., Safford, M., Loken, M.R., Zurlutter, K., Büchner, Th., Hiddemann, W. & Wörmann, B. (1991a) Flow cytometric characterization of acute myeloid leukemia. I. Significance of light-scattering profiles. Leukemia, 5, 315-321.
33. Terstappen, L.W.M.M., Meredith, S., Könemann, S., Loken, M.R., Zurlutter, K., Büchner, T., Hiddeman, W. & Wörmann, B. (1991b) Flow cytometric characterization of acute myeloid leukemia. II. Phenotypic heterogeneity at diagnosis. Leukemia, 5, 757-767.
34. Terstappen, L.W.M.M., Safford, M. & Loken, M.R. (1990b) Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia, 4, 657-663.
35. Watt, S.M., Fawcett, J., Murdoch, S.J., Teixeira, A.M., Geschmeissner, S.E., Hajibagheri, N.M. & Simmons, D.L. (1994) The CD66 identifies the biliary glycoprotein (BGP) adhesion molecule: cloning, expression, and adhesion functions of the GBPs splice variant. Blood, 84, 200-210.